Cytek Biosciences : Morgan Stanley Starts Cytek Biosciences at Equal-Weight With $26 Price Target
© MT Newswires 2021
| All news about CYTEK BIOSCIENCES, INC. |
|
| 05/16 | Piper Sandler Adjusts Price Target on Cytek Biosciences to $12 From $17, Reiterates Ove.. | MT |
| 05/12 | Morgan Stanley Lowers Price Target for Cytek Biosciences to $11 From $18, Maintains Equ.. | MT |
| 05/12 | INSIDER SELL : Cytek Biosciences | MT |
| 05/12 | Goldman Sachs Lowers Cytek Biosciences Price Target to $12 From $14, Buy Rating Maintai.. | MT |
| 05/12 | CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an.. | AQ |
| 05/11 | Cytek Biosciences Posts Flat Adjusted EPS, Higher Revenue for Q1; Sees 2022 Revenue at .. | MT |
| 05/11 | Cytek Biosciences Seeks M&A | CI |
| 05/11 | TRANSCRIPT : Cytek Biosciences, Inc., Q1 2022 Earnings Call, May 11, 2022 | CI |
| 05/11 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 EPS $0.01, vs. Street Est of $0.02 | MT |
| 05/11 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $35.1M, vs. Street Est of $3.. | MT |
| |
|
| Analyst Recommendations on CYTEK BIOSCIENCES, INC. |
|
| |
|
|
|
| Sales 2022 |
242 M
-
-
|
| Net income 2022 |
1,98 M
-
-
|
| Net cash 2022 |
366 M
-
-
|
| P/E ratio 2022 |
589x |
| Yield 2022 |
- |
|
| Capitalization |
1 319 M
1 319 M
-
|
| EV / Sales 2022 |
3,95x |
| EV / Sales 2023 |
4,40x |
| Nbr of Employees |
511 |
| Free-Float |
82,5% |
|
| Chart CYTEK BIOSCIENCES, INC. |
|
|
Duration :
Period :
|
 | |
|
Technical analysis trends CYTEK BIOSCIENCES, INC.
| Short Term | Mid-Term | Long Term | | Trends | Neutral | Bearish | Bearish |
Income Statement Evolution
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
4 |
| Last Close Price |
9,82 $ |
| Average target price |
11,67 $ |
| Spread / Average Target |
18,8% |
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
